Drug Trial Radar · NCT06693609
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
May 8, 2025
Primary completion
Dec 10, 2025
Study completion Dec 10, 2025
Sponsor
- Lead sponsor
- atai Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- EmpathBio, Inc.
- First posted
- Nov 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 2 study (protocol number EMP-01-201) will determine the safety and tolerability of a short-term treatment with an oral dosage form of EMP-01 in adult participants with social anxiety disorder (SAD) and will assess exploratory efficacy of repeated doses of EMP-01 versus placebo.
Conditions
- Social Anxiety Disorder
Interventions
EMP-01Drug
EMP-01 capsules
EMP-01 PlaceboDrug
EMP-01 placebo capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of treatment emergent adverse events, adverse events of special interest and serious adverse events.Time frame: Day 1 to EOS [Day 43]
- Incidence of clinically significant abnormalities in physical examinations, vital signs, electrocardiogram parameters, and safety laboratory results.Time frame: Day 1 [post-dose] to Day 57
- Columbia-Suicide Severity Rating Scale (C-SSRS) ScoreTime frame: Baseline to Day 57
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
MAC Clinical Research Centre, West Yorkshire
Leeds, United Kingdom
MAC Clinical Research - South Staffordshire
Bridgetown, Cannock, Staffordshire, United Kingdom
MAC Clinical Research - Greater Manchester
Manchester, Greater Manchester, United Kingdom
MAC Clinical Research - Lancashire
Blackpool, Lancashire, United Kingdom
MAC Clinical Research - Merseyside
Liverpool, Merseyside, United Kingdom
MAC Clinical Research - South Yorkshire
Tankersley, South Yorkshire, United Kingdom
MAC Clinical Research - Teesside
Thornaby, Stockton-on-Tees, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.